# FDA recall D-203-2013

> **Watson Laboratories Inc** · Class II · drug recall initiated 2013-02-08.

## Product

Meprobamate, Tablets USP, 200 mg, 100 tablets; Rx only;  Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 9591-5239-01

## Reason for recall

Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate  because an out of specification result for an impurity diphenyl sulfone .

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-203-2013
- **Recalling firm:** Watson Laboratories Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-02-08
- **Report date:** 2013-03-27
- **Termination date:** 2014-01-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Corona, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-203-2013

## Citation

> AI Analytics. FDA recall D-203-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-203-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*